Carl E Allen MD
Professor, Pediatric Hematology & Oncology, Baylor College of Medicine
Join to View Full Profile
6701 Fannin St.Suite 1400Houston, TX 77030
Phone+1 832-822-4242
Dr. Allen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Nationwide Children's Hospital/Ohio State UniversityResidency, Pediatrics, 2002 - 2005
Ohio State University College of MedicineClass of 2002
Certifications & Licensure
TX State Medical License 2008 - 2025
OH State Medical License 2003 - 2005
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis Start of enrollment: 2013 Jul 01
- Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A Start of enrollment: 2012 Dec 19
- A Study for Long-term Follow-up of Hemophagocytic Lymphohistiocytosis (HLH) Participants Who Received Treatment With Emapalumab (NI-0501), an Anti-interferon Gamma Monoclonal Antibody Start of enrollment: 2014 Aug 04
- Join now to see all
Publications & Presentations
PubMed
- Diagnostic BRAFV600E blood predicts treatment failure and neurodegeneration and redefines paradigms of pediatric LCH.Howard Lin, Akanksha Batajoo, Erin Peckham-Gregory, Daniel Zinn, Olive S Eckstein
Blood. 2025-04-01 - Genomic Alterations in Langerhans Cell Histiocytosis.Nitya Gulati, Erin Peckham-Gregory, D Williams Parsons, Carl E Allen
Hematology/oncology Clinics of North America. 2025-03-24 - High-Dose Methotrexate Usage Without Drug-Level Monitoring in Advanced Pediatric Mature B-Cell Non-Hodgkin Lymphoma in a Resource-Limited Setting in Malawi.Rizine R Mzikamanda, Loviisa Mulanje, Casey L McAtee, Apatsa Matatiyo, Zoe Mwale
JCO Global Oncology. 2025-03-01
Journal Articles
- Case Report: Secondary Hemophagocytic Lymphohistiocytosis with Disseminated Infection in Chronic Granulomatous Disease—A Serious Cause of MortalityCaridad A Martinez, Carl E Allen, Prakash Satwani, Frontiers in Immunology
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood
Abstracts/Posters
- TCR Repertoire Clonality Analysis and Transcriptome Analyses of Immune Infiltrates in Patients with Langerhans Cell Histiocytosis Can Define Prognostic Biomarkers for ...Carl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCHCarl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Genomic Characterization of a Pediatric Cohort with Non-Malignant Lymphoproliferative DisordersCarl E. Allen, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Mutated Blood Cells Define Clinical Risks in Langerhans Cell Histiocytosis, Paving the Way for Better Diagnosis and TreatmentApril 1st, 2025
Mutated Blood Cells Define Clinical Risks in Langerhans Cell HistiocytosisApril 1st, 2025- NCI-COG Pediatric MATCH Study Shows Benefit of Genetic Screening in Refractory TumorsApril 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
